Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Verri

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Oncotarget|October 10, 2015
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2017
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung CancersCarla Verri, Cristina Borzi, Todd Holscher, et al.
Cancer|January 21, 2010
Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer riskMattia Cremona, Elisa Calabrò, Giorgia Randi, et al.
Oncotarget|May 10, 2014
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypesErica Lorenzetto, Monica Brenca, Mattia Boeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial studyGabriella Sozzi, Mattia Boeri, Marta Rossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective StudyMattia Boeri, Massimo Milione, Claudia Proto, et al.
Oncotarget|February 22, 2018
Complement C4d-specific antibodies for the diagnosis of lung cancerDaniel Ajona, Marcin Okrój, María J Pajares, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2008
Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer projectCarla Verri, Luca Roz, Davide Conte, et al.
International Journal of Cancer|November 15, 2018
Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer riskOrazio Fortunato, Cristina Borzi, Massimo Milione, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trialMarco Platania, Felice Pasini, Luca Porcu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Oncotarget|October 10, 2015
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2017
Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung CancersCarla Verri, Cristina Borzi, Todd Holscher, et al.
Cancer|January 21, 2010
Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer riskMattia Cremona, Elisa Calabrò, Giorgia Randi, et al.
Oncotarget|May 10, 2014
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypesErica Lorenzetto, Monica Brenca, Mattia Boeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial studyGabriella Sozzi, Mattia Boeri, Marta Rossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective StudyMattia Boeri, Massimo Milione, Claudia Proto, et al.
Oncotarget|February 22, 2018
Complement C4d-specific antibodies for the diagnosis of lung cancerDaniel Ajona, Marcin Okrój, María J Pajares, et al.
American Journal of Respiratory and Critical Care Medicine|December 20, 2008
Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer projectCarla Verri, Luca Roz, Davide Conte, et al.
International Journal of Cancer|November 15, 2018
Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer riskOrazio Fortunato, Cristina Borzi, Massimo Milione, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trialMarco Platania, Felice Pasini, Luca Porcu, et al.
Pageof 2